Project Grant R44EY023505
Award Date 9/30/13
Completion Date 8/31/23
Dollars Obligated $4M
Federal Agency
Awardee
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Virginia, USA
Similar Awards
- Federal Project Grant Award Summary Kineolabs, Inc. received a $300,001 Project Grant from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867) to develop a portable, low-cost line-scan swept-source optical coherence tomography imaging system (LS-SS-OCT). The system is designed for early detection and monitoring of age-related macular degeneration (AMD), diabetic retinopathy, and other eye diseases. The one-year project, which commenced July 1, 2025 and concludes June...
- Federal Grant Award Summary The National Eye Institute awarded The Aird a $610,000 Project Grant under the Vision Research program (CFDA 93.867) beginning September 1, 2025, with completion targeted for August 31, 2026. The primary deliverable is the development and validation of a novel Adaptive Optics Optical Coherence Tomography (AO-OCT) system designed for high-resolution, wide-field retinal imaging in rodent models, specifically mice. The system will integrate adaptive optics technology...
- Under this $375,940 Phase I Small Business Innovation Research (SBIR) award from the National Eye Institute's Vision Research program (CFDA 93.867), Neurofieldz Inc. is developing and validating the NeuroVEP system, a portable wireless diagnostic device for objective assessment of optic neuropathies and other diseases affecting the afferent visual system. The NeuroVEP system utilizes electric field encephalography to measure visual evoked potentials (VEP) at the visual cortex in response to...
- This $976,308 National Science Foundation project grant funds the University of Miami to develop a novel fundus multiwavelength imaging device for simultaneous multiwavelength imaging of the retinal nerve fiber layer. The goal is to design, construct, and validate a non-contact optical method that can sensitively detect early glaucoma damage through in vivo measurement of retinal spectral reflectance changes. Specifically, the University of Miami will design and construct a new fundus imaging...
- Federal Project Grant Award Summary Eye C Better Corp received a $315,825 Project Grant from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867), effective September 1, 2025 through August 31, 2026. The award funds development of a novel, non-invasive intraocular pressure (IOP) measurement technology called Photonic IOP Biomonitoring (PIB) designed to address glaucoma management challenges. Glaucoma affects over 5 million Americans and costs the U.S. economy...
- Project Grant Summary: Improving Accessibility of Vision Research and Therapy Using an Open-Source Extended-Reality Platform Northeastern University received a $1.93M Project Grant from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867), awarded September 1, 2025, with completion targeted for April 30, 2030. The project will develop an open-source extended-reality (XR) platform designed to democratize access to vision science assessments and interventions for...
- This Project Grant from the National Science Foundation's Technology, Innovation, and Partnerships program totaling $100,000 aims to develop a computational solution to evaluate optic nerve function. Specifically, the University of Nevada, Reno will use the funding to potentially create an affordable, convenient head-mounted display capable of remotely and routinely assessing the health of the optic nerve through afferent pupillary defect tests. This screening tool may allow doctors, including...
- Federal Project Grant Award Summary Vasoptic Medical, Inc. received a $500,000 Project Grant from the National Institute on Aging under the Aging Research program (CFDA 93.866), awarded September 20, 2025, with a completion date of September 19, 2026. The award funds development of VasoVue NV, a novel imaging platform designed to assess neurovascular reactivity (NVR) as an early-stage biomarker for Alzheimer's disease. The technology will stimulate the retina with flicker illumination and use...
- Federal Cooperative Agreement Summary Panluminate Inc., a woman-owned small business headquartered in New Haven, Connecticut, received a $1.74 million Cooperative Agreement from the National Eye Institute under the Vision Research program (CFDA 93.867) to develop Pan-Optix, an innovative multiplexed nanoscopy platform combining Pan-Expansion Microscopy (PAN-EXM) and FLASH-PAINT technologies. The award, which commenced September 1, 2025, and extends through April 30, 2029, funds the company's...
- Federal Grant Award Summary The National Eye Institute (NEI) awarded Oregon Health & Science University a $1.73 million Project Grant under the Vision Research program (CFDA 93.867) beginning September 1, 2025, with completion targeted for April 30, 2030. The award funds development of innovative ophthalmic imaging technologies and objective biomarkers to assess photoreceptor function and integrity in patients with retinal degeneration. The research addresses a critical clinical need by...
RETIVUE WF - A HANDHELD, HIGH-RESOLUTION, WIDE-FIELD RETINAL IMAGER
Posted 9/23/15
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $0 | 6/13/24 | ||
| Not listed | $634.2k | 8/24/21 | ||
| Not listed | $634.2k | 8/24/21 | ||
| Not listed | $0 | 1/13/21 | ||
| Not listed | $0 | 1/13/21 |